Active targeted Janus nanoparticles enable anti-angiogenic drug combining chemotherapy agent to prevent postoperative hepatocellular carcinoma recurrence
Xiu Ping Zhang, Xiang Jun Chen, Bo Zhao Li, Shuai Xu, Zhou Liang Wu, Ming Gen Hu, Zhi Ming Zhao, Guo Dong Zhao, Chang Rong Wang, Wei Hong, Su Ping Li, Lu Li, Chun Gang Wang, Guangjun Nie, Rong Liu
Dive into the research topics of 'Active targeted Janus nanoparticles enable anti-angiogenic drug combining chemotherapy agent to prevent postoperative hepatocellular carcinoma recurrence'. Together they form a unique fingerprint.